Targeting werner helicase with synthetic lethality in microsatellite instability cancers: Promising therapeutic approaches.
- Published in:
- Medcomm: Oncology, 2024, v. 3, n. 2, p. 1, doi. 10.1002/mog2.82
- By:
- Publication type:
- Article
Works matching IS 27696448 AND DT 2024 AND VI 3 AND IP 2
Results: 8
1
2
Self‐oxygenating hydrogel: Regulation of postsurgical tumor recurrence/metastasis and wound healing.
- Published in:
- Medcomm: Oncology, 2024, v. 3, n. 2, p. 1, doi. 10.1002/mog2.81
- By:
- Publication type:
- Article
3
Clinical homologous recombination repair gene reversion analysis identifies mechanisms of resistance to PARP inhibitors and platinum‐chemotherapy.
- Published in:
- Medcomm: Oncology, 2024, v. 3, n. 2, p. 1, doi. 10.1002/mog2.79
- By:
- Publication type:
- Article
4
VISTA‐targeted antibody‐drug conjugates exhibit potent antitumor effects on malignant pleural mesothelioma.
- Published in:
- Medcomm: Oncology, 2024, v. 3, n. 2, p. 1, doi. 10.1002/mog2.78
- By:
- Publication type:
- Article
5
Mechanism and application of acupuncture and electro‐acupuncture associated with cancer therapy.
- Published in:
- Medcomm: Oncology, 2024, v. 3, n. 2, p. 1, doi. 10.1002/mog2.73
- By:
- Publication type:
- Article
6
Pathogenic mechanisms and etiologic aspects of Mycobacterium avium subspecies paratuberculosis as an infectious cause of cutaneous melanoma.
- Published in:
- Medcomm: Oncology, 2024, v. 3, n. 2, p. 1, doi. 10.1002/mog2.72
- By:
- Publication type:
- Article
7
Transpiration of neurological phenomena in cancer: Long‐term depression (LTD) abrogates cancer stem cell memory and sensitizes it to metabolic therapy.
- Published in:
- Medcomm: Oncology, 2024, v. 3, n. 2, p. 1, doi. 10.1002/mog2.71
- By:
- Publication type:
- Article
8
Issue Information.
- Published in:
- Medcomm: Oncology, 2024, v. 3, n. 2, p. 1, doi. 10.1002/mog2.35
- Publication type:
- Article